Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David B. Carr is active.

Publication


Featured researches published by David B. Carr.


The American Journal of Medicine | 1997

Current concepts in the pathogenesis of Alzheimer's disease.

David B. Carr; Alison Goate; D. Phil; John C. Morris

Alzheimers disease (AD) affects a large proportion of the increasingly aging population of this country, with prevalence rates as high as 47% for those >85 years old and a total annual cost approaching


Journal of the American Geriatrics Society | 2000

Characteristics of motor vehicle crashes of drivers with dementia of the Alzheimer type.

David B. Carr; Janet M. Duchek; John C. Morris

70 billion. There is no currently validated test for detection of dementia of the Alzheimer type (DAT). Because of this and the insidious onset of the disease, the diagnosis may be missed by primary care physicians. Cerebral extracellular beta-amyloid deposition as senile plaques and intraneuronal neurofibrillary tangles appear to represent critical processes in the development of AD; however, whether and the extent to which these may also occur in nondemented aging is uncertain. Tangles occur primarily in medial temporal lobe structures (hippocampus, entorhinal cortex, and amygdala), and tangle density correlates with dementia severity. Plaques are diffusely distributed throughout the cerebral cortex, and are the neuropathologic hallmark of the disease. Aging is the primary risk factor for AD. After controlling for differential life expectancy, female sex still appears to be an additional risk factor. There may be a genetic component, in some cases based on family and twin studies. Allelic variation in the apolipoprotein E (Apo E) gene located on chromosome 19 represents another important risk factor. However, the diversity of gene mutations apparently responsible for the various forms of AD suggest that the disease is genetically heterogeneous. AD may be conceptualized as an imbalance between neuronal injury and repair. Oxygen free radicals may be involved in the cross-linking process of beta-amyloid aggregation, and antioxidants may represent a potential intervention. There may be a role for heavy metals in the pathogenesis of AD, but this remains controversial. Work continues toward possibly a cure or prevention, but more likely palliation, of AD, and the results of trials of anti-inflammatory agents, estrogen, and antioxidant therapy are anticipated in the near future.


Alzheimer Disease & Associated Disorders | 1997

DEMENTIA AND DRIVING: AN ATTEMPT AT CONSENSUS

Catarina Lundberg; Kurt Johansson; Karlene Ball; Bo Bjerre; Christopher Blomqvist; Anne Brækhus; Wiebo Brouwer; Frederick W. Bylsma; David B. Carr; Lars Englund; Robert P. Friedland; Liisa Hakamies-Blomqvist; Göran Klemetz; Desmond O'Neill; Gl Odenheimer; Matthew Rizzo; Margitta Schelin; Marianne Seideman; Karen Tallman; Matti Viitanen; Patricia F. Waller; Bengt Winblad

OBJECTIVE: To determine whether there is a difference in crash rates and characteristics between drivers with dementia of the Alzheimer type (DAT) and nondemented older persons who were controls.


Journal of the American Geriatrics Society | 2004

Older Driver Safety: A Report from the Older Drivers Project

Claire C. Wang; David B. Carr

Summary:The number of older drivers in Sweden will be rapidly increasing during the next decades. A possible relationship exists between the increased relative crash risk of older drivers and the prevalence of age-related diseases such as dementia. However, a clear-cut policy for evaluating driving competence in demented persons is still lacking. In recognition of this fact, the Swedish National Road Administration invited a group of researchers to formulate a consensus on the issue of driving and dementia. This consensus document is aimed at providing primary care physicians with practical advice concerning the assessment of cognitive status in relation to driving. Suggestions are based on a review of existing research and discuss the use of general and driving-specific sources of information available to the physician. Consensus was reached on the statement that a diagnosis of moderate to severe dementia precludes driving and that certain individuals with mild dementia should be considered for a specialized assessment of their driving competence.


Accident Analysis & Prevention | 2009

Motor-vehicle crash history and licensing outcomes for older drivers reported as medically impaired in Missouri

Thomas M. Meuser; David B. Carr; Gudmundur F. Ulfarsson

Older driver safety is a growing public health concern for which interventions are currently being sought. Statistics show that older drivers suffer a disproportionately high rate of motor vehicle fatalities compared with other adult drivers. This disproportion is due to two factors: an increased crash rate per vehicle mile driven and an increased risk of fatality in the event of a crash.


Journal of the American Geriatrics Society | 2006

Characteristics of frail older adult drivers.

David B. Carr; Kellie L. Flood; Karen Steger-May; Kenneth B. Schechtman; Ellen F. Binder

The identification and evaluation of medically impaired drivers is an important safety issue. Medical fitness to drive is applicable to all ages but is particularly salient for older adults. Voluntary procedures, whereby various professionals and family members may report medical fitness concerns to State driver license bureaus, are common in the United States. This paper examines traffic crashes of drivers reported during 2001-2005 under the State of Missouris voluntary reporting law (House Bill HB-1536) and the resulting licensing outcomes. Missouris law is non-specific as to age, but the mean age of reported drivers was 80. Reports were submitted by police officers (30%), license office staff (27%), physicians (20%), family members (16%), and others (7%). The most common medical condition was dementia/cognitive (45%). Crash history for reported drivers was higher than that of controls, dating back to 1993, reaching a peak in 2001 when the crash involvement of reported drivers was 9.3% vs. 2.2% for controls--a fourfold difference. The crash involvement of reported drivers decreased rapidly after, indicating the impact of HB-1536 reporting with subsequent license revocation and to a lesser degree, mortality. Of the 4,100 reported individuals, 144 (3.5%) retained a drivers license after the process.


Annals of Pharmacotherapy | 2014

Medications and Impaired Driving

Amanda J. Hetland; David B. Carr

OBJECTIVES: To determine the prevalence of driving in older adults with mild to moderate physical frailty and to compare characteristics of current frail older adult drivers with those of former drivers in the sample.


Geriatric Nursing | 1995

Alzheimer's disease: Assessing safety problems in the home

Helen W. Lach; A. Thomas Reed; Laurie J. Smith; David B. Carr

Objective: To describe the association of specific medication classes with driving outcomes and provide clinical recommendations. Data Sources: The MEDLINE and EMBASE databases were searched for articles published from January 1973 to June 2013 on classes of medications associated with driving impairment. The search included outcome terms such as automobile driving, motor vehicle crash, driving simulator, and road tests. Study Selection and Data Extraction: Only English-language articles that contained findings from observational or interventional designs with ≥ 10 participants were included in this review. Cross-sectional studies, case series, and case reports were excluded. Data Synthesis: Driving is an important task and activity for the majority of adults. Some commonly prescribed medications have been associated with driving impairment measured by road performance, driving simulation, and/or motor vehicle crashes. This review of 30 studies identified findings with barbiturates, benzodiazepines, hypnotics, antidepressants, opioid and nonsteroidal analgesics, anticonvulsants, antipsychotics, antiparkinsonian agents, skeletal muscle relaxants, antihistamines, anticholinergic medications, and hypoglycemic agents. Additional studies of medication impact on sedation, sleep latency, and psychomotor function, as well as the role of alcohol, are also discussed. Conclusions: Psychotropic agents and those with central nervous system side effects were associated with measures of impaired driving performance. It is difficult to determine if such associations are actually a result of medication use or the medical diagnosis itself. Regardless, clinicians should be aware of the increased risk of impaired driving with specific classes of medications, educate their patients, and/or consider safer alternatives.


Gerontology & Geriatrics Education | 2010

The American Medical Association older driver curriculum for health professionals: changes in trainee confidence, attitudes, and practice behavior

Thomas M. Meuser; David B. Carr; Cheryl Irmiter; Joanne G. Schwartzberg; Gudmundur F. Ulfarsson

providing a safe environment is a challenge for families and health professionals caring for patients with Alzheimers disease. 1 The progressive loss of memory, judgment, and motor functions may lead to hazardous behavior, resulting in accidents or injuries. Caregivers often ask for advice about how to provide safe care for those with Alzheimers disease. Despite some general knowledge of safety concerns, little is known about the prevalence, incidence, or home management of safety problems or accidents in Alzheimers disease and other dementias. Home safety problems, such as falls, wandering, unsafe driving, and physical violence, have long been reported in the study of behavioral problems in dementia. 16 And several publications provide suggestions for caregivers about safety problems and their management, as well as home modifications to assist people with memory problems in functioning and safety. 7-14 But we cannot predict who is at risk for safety problems or whether the severity of dementia increases the risk of safety problems. The purpose of this pilot study was to determine which safety problems were most common in our patient population, to explore the relationship between dementia severity


Journal of the American Medical Directors Association | 2008

Quality Improvement in Long Term Care: The Psychotropic Assessment Tool (PAT)

Lindsey J. Dahl; Rebecca Wright; Aiying Xiao; Angela Keeven; David B. Carr

Few gerontology and geriatrics professionals receive training in driver fitness evaluation, state reporting of unfit drivers, or transportation mobility planning yet are often asked to address these concerns in the provision of care to older adults. The American Medical Association (AMA) developed an evidence-based, multi-media Curriculum to promote basic competences. This study evaluated reported changes in practice behaviors 3 months posttraining in 693 professionals trained via the AMA approach. Eight Teaching Teams, designated and trained by AMA staff, offered 22 training sessions across the United States in 2006 to 2007. Trainees (67% female; mean age 46) completed a pretest questionnaire and a posttest administered by mail. Physicians were the largest professional group (32%). Although many trainees acknowledged having conversations with patients about driving at pretest, few endorsed utilizing specific techniques recommended by the AMA prior to this training. The posttest response rate was 34% (n = 235). Significant improvements in reported attitudes, confidence, and practices were found across measured items. In particular, posttest data indicated new adoption of in-office screening techniques, chart documentation of driver safety concerns, and transportation alternative planning strategies. Findings suggest that a well-designed, one-time continuing education intervention can enhance health professional confidence and clinical practice concerning driver fitness evaluation and mobility planning. Targeted dissemination of this Curriculum (in-person and online) will allow more to benefit in the future.

Collaboration


Dive into the David B. Carr's collaboration.

Top Co-Authors

Avatar

Thomas M. Meuser

University of Missouri–St. Louis

View shared research outputs
Top Co-Authors

Avatar

Peggy P. Barco

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

John C. Morris

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Catherine M. Roe

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ganesh M. Babulal

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Denise Head

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Marian E. Betz

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elizabeth K. Vernon

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge